Product information
From Health Canada
The product monograph is developed by a drug sponsor according to guidelines published by Health Canada that provide direction on the content and format. The veterinary labelling is developed by the drug sponsor according to the Food and Drug Regulations. While Health Canada reviews the product monograph or the veterinary labelling as part of the drug review process, it remains the responsibility of the drug sponsor to ensure that the product monograph or the veterinary labelling is complete and accurate.
Current status:
Marketed
Current status date:
2019-03-26
Original market date: See footnote 1
2019-03-26
Product name:
NEOSTIGMINE METHYLSULFATE INJECTION USP
DIN:
02475499
Product Monograph/Veterinary Labelling:
Date:
2018-05-08
Product monograph/Veterinary Labelling (PDF version ~ 175K)
Company:
MARCAN PHARMACEUTICALS INC
2 Gurdwara Rd., Suite 112
Ottawa
Ontario
Canada
K2E 1A2
Class:
Human
Dosage form(s):
Solution
Route(s) of administration:
Subcutaneous , Intramuscular , Intravenous
Number of active ingredient(s):
1
Schedule(s):
Prescription
American Hospital Formulary Service (AHFS): See footnote 3
12:04.00
Anatomical Therapeutic Chemical (ATC): See footnote 4
N07AA01 NEOSTIGMINE
Active ingredient group (AIG) number:See footnote5
0102263003
| Active ingredient(s) See footnote8 | Strength |
|---|---|
| NEOSTIGMINE METHYLSULFATE | 1 MG / ML |